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Edited by Miguel De la RosaAbstract The sequences of rat testis carbonyl reductase (rCR1)
and rat ovary carbonyl reductase (rCR2) are 98% identical, dif-
fering only at amino acids 140, 141, 143, 235 and 238. Despite
such strong sequence identity, we ﬁnd that rCR1 and rCR2 have
diﬀerent catalytic constants for metabolism of menadione and
4-benzoyl-pyridine. Compared to rCR1, rCR2 has a 20-fold low-
er Km and 5-fold lower kcat towards menadione and a 7-fold low-
er Km and 7-fold lower kcat towards 4-benzoyl-pyridine. We
constructed hybrids of rCR1 and rCR2 that were changed at
either residues 140, 141 and 143 or residues 235 and 238.
rCR1 with residues 140, 141 and 143 of rCR2 has similar cata-
lytic eﬃciency for menadione and 4-benzoyl-pyridine as rCR1.
rCR1 with Thr-235 and Glu-238 of rCR2 has the catalytic con-
stants of rCR2, indicating that it is this part of rCR2 that con-
tributes to its lower Km for menadione and 4-benzoyl-pyridine.
Comparisons of three-dimensional models of rCR1 and rCR2
show how Thr-235 and Glu-238 stabilize rCR2 binding of
NADPH and menadione.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Xenobiotics1. Introduction
Carbonyl reductase (CR) catalyses the NADPH-dependent
reduction of various endogenous carbonyl compounds and
androgens [1–5]. CR belongs to the short-chain dehydrogen-
ases/reductases (SDR) superfamily [6], a large family of en-
zymes that catalyze the oxidation or reduction of a wide
variety of substrates, including steroids and prostaglandins
[6,7].
In 1995, we determined the amino acid sequence of CR
(rCR1) from rat testis [8] and found it to be about 80% identical
to human CR [1]. Two years later, Aoki et al. [5] characterized a
second rat CR (rCR2) from ovary that was inducible by preg-
nant mare serum gonadotropin. They did not express rCR2 and
study its catalytic activity, which seemed unnecessary because
the amino acid sequences of rCR1 and rCR2 are 98% identical;
they diﬀer in only ﬁve residues: 140, 141, 143, 235 and 238.With
such strong similarity, it is reasonable to assume that rCR1 and*Corresponding authors. Fax: +41 31 632 4862 (B. Wermuth), +1 619
543 7069 (M.E. Baker).
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doi:10.1016/j.febslet.2005.11.049rCR2 have similar enzymatic properties. However, the ﬁve dif-
ferences are localized to two sites that have interesting func-
tional properties. The amino acids at 140, 141, and 143 are
close to the catalytically important serine-139 [6,9]. In rat
CR1 and human CR, amino acid 238 is a lysine that is cova-
lently modiﬁed by an autocatalytic reaction with 2-oxocarb-
oxylates, such as pyruvate [4,10,11]. Lysine-238 is replaced
with glutamic acid in rat CR2. The potential functional impor-
tance of these diﬀerences between rCR1 and rCR2 prompted us
to investigate their catalytic properties in more detail.
Here we show that despite 98% amino acid identity between
rCR1 and rCR2, they have diﬀerent catalytic constants for
menadione and 4-benzoyl-pyridine. By constructing hybrids
that diﬀer either at residues 140, 141 and 143 or at residues
235 and 238, we determined that Thr-235 and Glu-238 are
responsible for the diﬀerent catalytic properties of rCR1 and
rCR2. Comparison of three-dimensional models of rCR1
and rCR2 with NADPH and menadione, which we con-
structed, indicates that Thr-235 has important stabilizing inter-
actions with NADPH and menadione, and Glu-238 stabilizes
Trp-229, which interacts with menadione. Our data show that
rCR1 and rCR2 in testes and ovary, respectively, are an exam-
ple of how small changes in amino acid can lead to the evolu-
tion of diﬀerent catalytic constants in an enzyme.2. Materials and methods
2.1. Materials
For mutagenesis and expression of rat CRs, we used rcr1 recombi-
nant cDNA, subcloned into a pET-11 inducible expression vector from
a kgt11 rat testis cDNA library as previously described [8]. Genomic
rat DNA was prepared from male Sprague–Dawley rat blood.
2.2. Mutagenesis
rcr2 and mutant genes rcr1/2 and rcr2/1 were constructed by mutat-
ing the corresponding recombinant rcr1 cloned in pET11a by the Hig-
uchi method [12]. rcr2/1 is a S140G, V141M, L143R mutant of rcr1.
rcr1/2 is a A235T, K238E mutant of rcr1. We sequenced each mutant
to verify that the only mutations were those at the desired amino acids
in rCR.
PCR products obtained with the expand high ﬁdelity PCR system
were cloned into the PCR-product cloning vector pT-Adv. rcr mutants
were digested by KpnI and NcoI and inserted into recombinant rcr1
cloned in pET11a.
2.3. Recombinant gene expression and enzyme puriﬁcation
Recombinant plasmids were transfected into Escherichia coli BL21
by electroporation and plated on LB agar containing 50 lg/ml ampicil-
lin. A clone was cultured in LB containing 50 lg/ml ampicillin. Expres-
sion was induced by adding 0.4% IPTG to the culture. After 5 h, cellsblished by Elsevier B.V. All rights reserved.
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Tris–HCl, pH 8.6, containing 1 mM EDTA and disrupted by freeze–
thawing and sonication. The supernatant was treated with RNAses
and DNAse, 10 lg/ml each, for 5 min on ice. CR was puriﬁed by chro-
matography on DEAE cellulose, using a NaCl gradient from 0 to
200 mM. Homogeneity was determined with SDS–PAGE [13], using
silver staining and Western analysis in parallel.
2.4. Enzymatic assay and kinetic analysis
Kinetic characterization of rat CR and its mutants was determined
by following oxidation of NADPH at 340 nm in the presence of vary-
ing concentrations of menadione and 4-benzoyl-pyridine with
0.05 mM NADPH in 100 mM phosphate buﬀer, pH 7.0. Km and kcat
values were determined from Lineweaver–Burk plots.
2.5. Construction of molecular models of rCR1 and rCR2
The template for modeling rCR1 and rCR2 was the 3D structure of
pig CR, which has been solved with NADPH [PDB ﬁle 1N5D] [14].
The amino acid sequence of pig CR is about 80% identical to that of
rCR1 and rCR2. At this degree of sequence identity, the two rCR
3D models will be good representations of the true 3D structure.
Initial 3D models of rCR1 and rCR2 were constructed with the
Accelrys Insight II software using the Homology option [15]. To insert
menadione into rCR1 and rCR2, we superimposed the initial rCR 3D
models with NADPH onto mouse carbonyl reductase [PDB ﬁle
1CYD]. The isopropanol substrate was extracted from 1CYD and in-
serted into rCR1 and rCR2. Then menadione was superimposed onto
isopropanol in the four possible orientations and each rCR was mini-
mized using Discover 3 and the CVFF force ﬁeld for 120000 iterations.3. Results and discussion
3.1. Enzymatic activity of rCR1 and rCR2
We compared the catalytic activity of rCR1 and rCR2 for
menadione and 4-benzoyl-pyridine. As shown in Table 1, com-
pared to rCR1, rCR2 has a lower Km towards these substrates.
The Kms of rCR1 for menadione and 4-benzoyl-pyridine are 70
and 1100 lM, respectively. In contrast, the Kms of rCR2 for
menadione and 4-benzoyl-pyridine are 3.3 and 150 lM, respec-
tively. This 20-fold diﬀerence between rCR1 and rCR2 in the
Km for menadione was unexpected. Similarly, there are large
diﬀerences between rCR1 and rCR2 in kcat for menadione
and 4-benzoyl-pyridine.
rCR1 and rCR2 diﬀer by only ﬁve amino acids in two re-
gions: (a) residues 140, 141, and 143 and (b) residues 235
and 238. To determine the contribution of these amino acids
to the diﬀerences in catalytic activity of rCR1 and rCR2, we
constructed two intermediate mutants, rCR1/2 and rCR2/1.
rCR1/2 is identical to rCR1 at positions 140, 141, and 143
and identical to rCR2 at positions 235 and 238. rCR2/1 is iden-Table 1
Kinetic constants for testicular and ovarian rat carbonyl reductase and
hybrid mutants
Protein Menadione 4-Benzoyl-pyridine
Km kcat Km kcat
rCR1 70 lM 4.1 1100 lM 4.75
rCR2/1 350 lM 12.5 1400 lM 14.5
rCR1 A235T 30 lM 4.0 1050 lM 1.4
rCR1 K238E 20 lM 2.0 240 lM 5.6
rCR1/2 3.9 lM 0.9 150 lM 0.85
rCR2 3.3 lM 0.8 150 lM 0.7
rCR2/1 = (rCR1 + G140, M141, R143); rCR1/2 = (rCR1 + T235,
E238).tical to rCR1 at positions 235 and 238 and identical to rCR2 at
positions 140, 141, and 143.
Table 1 summarizes the Km and kcat of rCR1/2 and rCR2/1
for menadione and 4-benzoyl-pyridine. There are signiﬁcant
diﬀerences between these two mutants. The catalytic constants
for rCR1/2 are close to those of rCR2, while those for rCR2/1
are higher than those of rCR1. For example, the Km and kcat
of rCR2/1 for menadione are 5-fold and 3-fold higher than
those of rCR1. This indicates weaker binding of menadione
to rCR2/1, which is consistent with a higher turnover of the
substrate.
The closeness of the catalytic constants of rCR1/2 to rCR2
prompted us to look at the individual contributions of the dif-
ferences at residues at 235 and 238 to the change in catalytic
activity. To do this, we constructed two rCR1 mutants,
rCR1(A235T) and rCR1(K238E). As shown in Table 1, com-
pared to rCR1, some of the kinetic constants of rCR1(A235T)
and rCR1(K238E) are closer to those of rCR2 and some are
closer to rCR1. For example, rCR1(K238E) has a Km for 4-
benzyl pyridine that is close to that of rCR2, while kcat for
4-benzoyl-pyridine a little higher than that of rCR1. This indi-
cates that it is combination of the two mutations that is
responsible for the diﬀerences between rCR1 and rCR2 in
reduction of menadione and 4-benzoyl-pyridine.
3.2. Construction and analysis of 3D models of rCR1 and rCR2
To seek clues to the structural basis for the eﬀect of Thr-235
and Glu-238 on substrate binding to rCR2, we constructed 3D
models of rCR1 and rCR2 with NADPH and menadione. We
superimposed the Ca backbones backbones of rCR1 and rCR2
and ﬁnd that the RMS diﬀerence between their backbones is
0.39 (Fig. 1, Supplement). Upon examination of the over-
lapped models, we did not ﬁnd evidence for an allosteric inter-
action that would inﬂuence the catalytic activity of rCR1 and
rCR2. As discussed below, the distances between NADPH and
the three catalytically important residues: Ser-139, Tyr-193
and Lys-197 [14,16] are consistent with those in pig CR [14]
and similar to those found for other SDRs [6,9,14,17–20],
which gives us conﬁdence in our 3D models.
Menadione can assume four diﬀerent orientations in the sub-
strate-binding site in rCR (Fig. 1). It is not clear if more than
one of these orientations is suitable for a productive catalytic
interaction with tyrosine-193 and NADPH. To resolve this
question, we constructed 3D models with menadione in each
orientation in rCR1 and rCR2. Both orientations of menadi-
one, in which the quinone is pointing into the interior of the
active site of rCR1 and rCR2 (Fig. 2) have favorable distances
between the quinone and the catalytically important residues
and NADPH. This is consistent with the reduction of ketone,
at C1 and C4 of menadione by rCR. Menadione with the qui-
none pointing away from the catalytic site has less favorable
distances to key residues.
Analysis of the 3D models of rCR1 and rCR2 provides an
explanation for the stabilizing eﬀects of Thr-235 and Glu-238
in rCR2. As seen in Fig. 2B, in rCR2, Thr-235 Oc is about
3A from the nicotinamide N7 and O7. Thr-235 Oc also can
interact with the methyl group on menadione. Instead of the
hydroxyl side chain of Thr-235, which can form hydrogen
bonds with the nicotinamide moiety, Ala-235 of rCR1 has a
methyl group as a side chain (Fig. 2A). Thus, Ala-235 is not
a hydrogen-bond partner for the nicotinamide group. More-
over, Ala-235 Cb is about 3.75A from the nicotinamide N7
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Fig. 1A. Interior orientation of menadione quinone in rCR2 sub-
strate-binding site.
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Fig. 1B. Exterior orientation of menadione quinone in rCR2 sub-
strate-binding site.
Fig. 2A. Model of Ala-235 and Lys-238 in rCR1.
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group to inﬂuence its position in the substrate-binding site.
Unexpectedly, we found that Glu-238 stabilizes menadione
through a relay with Trp-229. As shown in Fig. 2B, the back-
bone oxygen on Glu-238 is about 3A from Ne1 of Trp-229,
which stabilizes the ketone that is not being reduced on men-
adione. In contrast, the backbone oxygen in Lys-238 inrCR1 is about 4A from Ne1 in Trp-229 (Fig. 2A). This is a
weaker interaction with Trp-229.
The 3D model indicates that the residues 140, 141 and 143 of
rCR1 of rCR2 appear to perform similar structural functions
in each enzyme. In rCR1, Ser-140 interacts with the ketone
on menadione that is being reduced (Fig. 2C). Cc1 of Val-
141 is about 4A from this ketone; Cc2 is about 4A from Cd2
Fig. 2B. Model of Thr-235 and Glu-238 in rCR2.
Fig. 2C. Model of Ser-140, Val-141 and Leu-143 in rCR1.
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actions with the substrate or catalytic residues.
In rCR2, Met-141 is about 4A from the ketone on menadi-
one that is reduced (Fig. 2D). Met-141 also interacts with Tyr-
193. Arg-143 does not appear to have important interactions
with the substrate or catalytic residues.The 3D models (Figs. 2C and 2D) show that Ser-139 and
Tyr-193, which is part of the catalytic triad of CR [6,14,16]
are farther from each other in rCR2 than in rCR1. This may
explain the increased Km found in rCR2/1.
rCR2 is unique among mammalian CRs in having an amino
acid at 235 with an alcohol side chain and an amino acid at 238
Fig. 2D. Model of Gly-140, Met-141 and Arg-143 in rCR2.
 
 
 
 
Fig. 3. Alignment of several carbonyl reductases near residues 235 and
238.
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man CR and mouse CR have alanine-235 and lysine-238
[15]. Pig CR has a glycine-235. Rabbit CR has glycine-235
and asparagine-238. The two apparently small evolutionary
changes in rCR2 increase its aﬃnity for menadione (Table
1). Our data raise the intriguing possibility that diﬀerences in
positions 235 and 238 in other CRs may be functionally impor-
tant.
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